First human clinical trial of potential COVID-19 vaccine Covaxin administered at AIIMS
New Delhi: The phase-I human clinical trial of India's first indigenously-developed vaccine against novel coronavirus, Covaxin, began at the AIIMS here on Friday with the first dose of the injection given to a man, who is in his 30s. Already, over 3,500 volunteers have registered...











































